797
Views
0
CrossRef citations to date
0
Altmetric
Commentary on selected article in this issue

Splenectomy and second malignancies in patients with Hodgkin lymphoma: is there a causal relationship?

&

References

  • Weledji EP. Benefits and risks of splenectomy. Int J Surg 2014; 12:113–119.
  • Kristinsson SY, Gridley G, Hoover RN, et al. Long-term risks after splenectomy among 8,149 cancer-free US veterans: a cohort study with up to 27 years follow-up. Haematologica 2014;99:392–398.
  • Mellemkjøer L, Olsen JRH, Linet MS, et al. Cancer risk after splenectomy. Cancer 1995;75:577–583.
  • Dietrich P, Henry-Amar M, Cosset J, et al. Second primary cancers in patients continuously disease-free from Hodgkin’s disease: a protective role for the spleen? Blood 1994;84:1209–1215.
  • van Leeuwen FE, Klokman W, Hagenbeek A, et al. Second cancer risk following Hodgkin’s disease: a 20-year follow-up study. J Clin Oncol 1994;12:312–325.
  • Hull CC, Galloway P, Gordon N, et al. Splenectomy and the induction of murine colon cancer. Arch Surg 1988;123:462.
  • Sato N, Michaelides MC, Wallack MK. Effect of splenectomy on the growth of murine colon tumors. J Surg Oncol 1983;22:73–76.
  • Dailey MO, Coleman CN, Fajardo LF. Splenic injury caused by therapeutic irradiation. Am J Surg Pathol 1981;5:325–332.
  • Holroyde CP, Oski FA, Gardner FH. The pocked erythrocyte: red-cell surface alterations in reticuloendothelial immaturity of the neonate. N Engl J Med 1969;281:516–520.
  • Bonadonna G, Viviani S, Bonfante V, et al. Survival in Hodgkin's disease patients—report of 25 years of experience at the Milan Cancer Institute. Eur J Cancer 2005;41:998–1006.
  • Swerdlow AJ, Higgins CD, Smith P, et al. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study. J Clin Oncol 2011;29:4096–4104.
  • Delwail V, Jais JP, Colonna P, et al. Fifteen–year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high–dose irradiation. Br J Haematol 2002;118:189–194.
  • van Leeuwen FE, Klokman WJ, van't Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000;18:487–497.
  • Bonadonna G, Zucali R, Monfardini S, et al. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 1975; 36:252–259.
  • Kooistra HAM, Kluin-Nelemans HC, van Imhoff GW, et al. Splenectomy and second malignancies in patients with Hodgkin lymphoma. Leuk Lymphoma 2015;56:242–243.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.